Suchergebnisse für “Test C-S4CS-2408 Preparation 🤢 C-S4CS-2408 Braindump Pdf 😘 Study C-S4CS-2408 Center 🖌 Search for ➡ C-S4CS-2408 ️⬅️ on [ www.pdfvce.com ] immediately to obtain a free download 💮Latest C-S4CS-2408 Exam Labs”
Solar-Recur: A Phase 3, Multicenter, Open-label Study to Test the Diagnostic Performance of Copper Cu 64 PSMA I&T PET/CT in Men with Biochemical Recurrence of Prostate Cancer
Detectnet™
Solar-Stage: A Phase 3, Multicenter, Open-label Study to Test the Diagnostic Performance of Copper Cu 64 PSMA I&T PET/CT in Staging of Men with Newly Diagnosed Unfavorable Intermediate-risk, High-risk or Very High-risk Prostate Cancer Electing to Undergo Radical Prostatectomy with Pelvic Lymph Node Dissection
RadioMedix and Curium Announce FDA Approval of Detectnet (copper Cu 64 dotatate injection) in the U.S.
Ultratag™ RBC
Ultratag™ RBC
Curium announces publication of [18F]DCFPyL versus [18F]fuoromethylcholine results from European phase III Study (PYTHON trial)
Curium announces publication of [18F]DCFPyL versus [18F]fuoromethylcholine results from European phase III Study (PYTHON trial)
Nuclear medicine education
Welcome customers Thank you for visiting our Nuclear Medicine Education website. Through this website we strive to provide a robust variety of Continuing Education (CE) programs relevant to the Nuclear Medicine Technologist. All courses are structured in a self-paced learning format, conveniently accessible 24 hours a day, 7 days a week, and include course assessments […]
Kit for the Preparation of Technetium Tc 99m Sestamibi Injection
Kit for the Preparation of Technetium Tc99m Sestamibi Injection
Curium Announces FDA Approval of a Generic Version of DaTscan™ (Ioflupane I 123 Injection) in the U.S.
Curium Announces Approval of PulmotechTM MAA (kit for the preparation of technetium Tc 99m albumin aggregated injection) by the U.S. Food and Drug Administration
Ressourcen
Curium Announces The Submission Of Its Marketing Authorization Application For [18F]-DCFPyL To The European Medicines Agency
Technescan™ PYP™
Technescan™ HDP
Curium U.S. invoice terms and conditions of sale
Technescan MAG3™
Technescan MAG3™
Curium Expands Nuclear Medicine Offerings, Announces U.S. Availability of Xenon Xe 133 Gas
Curium announces last patient enrolled in their Phase 1/2 SOLAR clinical trial imaging men with histologically-proven metastatic prostate cancer using copper Cu 64 PSMA I&T
Curium Announces New Indication for Ioflupane I 123 Injection in the U.S.
Ioflupane I 123 Injection
Europäische Produkte
Curium Announces Revised Pricing for Technescan MAG3TM (kit for the preparation of technetium Tc 99m mertiatide)
Sodium Iodide I-123 Capsules
Octreoscan™
Octreoscan™
Startseite
RadioMedix and Curium Announce copper Cu 64 dotatate injection Was Granted Priority Review by the U.S. FDA
RadioMedix and Curium Announce FDA Filing of copper Cu 64 dotatate injection New Drug Application
Curium und RadioMedix geben eine exklusive Vereinbarung für die 64Cu-Dotatate-Entwicklung bekannt.
NRG and Curium Sign Multi-Year Isotope Production Contract
Pulmotech™ MAA
Curium to Expand Noblesville Facility’s Workforce
Curium Acquires Austrian Radiopharmaceuticals Company IASON
Curium confirms no supply challenges in North America and Europe for its ECLIPSE Phase 3 clinical trial
Ultra-Technekow™ V4
30 Years in NETs
Ultra-Technekow™ V4
Kooperation von Curium und ROTOP zur Versorgung von Patienten mit STRIASCANTM
Curium enhances its position in the French PET market with the completion of the acquisition of Cyclopharma’s French commercial and manufacturing operations
Curium Acquires Finnish Radiopharmaceuticals Company MAP Medical Technologies Oy
Curium Acquires Zevacor Molecular Strengthening Its PET Portfolio
Curium Announces Drug Master File and Active Substance Master File for Germanium-68 in the U.S. and Europe
Curium to become major player in the supply on non carrier added Lu-177
Nuclear Medicine Outlook: Proven Molybenum-99 Supply Chain Reliability and New Planned Capacity Continue to Benefit Patients
Curium’s Customers to benefit from Mo-99 Production restart
Curium’s 14 million patients to benefit from regular supply of Mo-99 and TC-99
APhA Annual Meeting & Exposition
From March 23-25, we will be attending the 9th edition of Journées Francophones de Médecine Nucléaire (JFMN) at the Belfri de Montrouge, in the Paris region, France. Meet Curium team at booth 45B and attend our symposium presentation to gain insights into our multiomic approach to patient care. Symposium Presentation Speakers: PR.PY. SALAÜN, Dépistage de […]
Eine Erklärung von Curium zu COVID-19 und unseren Maßnahmen
Curium Prague, Czech Republic
Gallium Citrate Ga 67 Injection
Xenon Xe 133 Gas
BNMS – British Nuclear Medicine Society
From March 23-25, we will be attending the 9th edition of Journées Francophones de Médecine Nucléaire (JFMN) at the Belfri de Montrouge, in the Paris region, France. Meet Curium team at booth 45B and attend our symposium presentation to gain insights into our multiomic approach to patient care. Symposium Presentation Speakers: PR.PY. SALAÜN, Dépistage de […]